ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

Targeting inflammation-driven tumor progression with Zafirlukast via modulation of Jagged-1/Notch-1/Hes-1, Wnt-4/β-catenin, and VEGF signaling pathways in mice.

Asmaa Saleh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.